DNAP
The computed 12-month bankruptcy probability of DNAP is 3.1% (moderate). The 2025 annual accounts show negative equity (€-64k) and a net result of €-34k. Equity is shrinking by ~53.1% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-64k |
| Net result | €-34k |
| Active | 5 yrs |
| Locations | 1 |
Mixed profile: strong on profitability, weaker on health.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €103k |
| Net profit | €-34k |
| Cash flow | €11k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €3.08M |
| Equity | €-64k |
| Debt | €3.15M |
| of which ≤ 1y | €1.08M |
| of which > 1y | €2.06M |
| Working capital | €-1.00M |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 0.07 |
| Quick ratio | 0.07 |
| Working capital ratio | -32.5% |
| Solvency | -2.1% |
| Debt / equity | -49.10 |
| Long-term debt ratio | -32.10 |
| Interest coverage | 1.12 |
| Gross margin | - |
| Net margin | - |
| ROA | -1.1% |
| ROE | 53.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €3.08M |
| Fixed assets | 21/28 | €3.00M |
| Tangible fixed assets | 22/27 | €3.00M |
| Financial fixed assets | 28 | €0 |
| Current assets | 29/58 | €79k |
| Amounts receivable within one year | 40/41 | €0 |
| Cash & bank | 54/58 | €75k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €3.08M |
| Equity | 10/15 | €-64k |
| Contributions / capital | 10/11 | €50k |
| Accumulated profits (losses) | 14 | €-114k |
| Amounts payable | 17/49 | €3.15M |
| Amounts payable after one year | 17 | €2.06M |
| Amounts payable within one year | 42/48 | €1.08M |
| Trade debts payable within one year | 44 | €8k |
| Income statement | ||
| Gross operating margin | 9900 | €113k |
| Operating result | 9901 | €57k |
| Financial income | 75 | €112 |
| Financial charges | 65 | €92k |
| Result before taxes | 9903 | €-34k |
| Net result for the period | 9904 | €-34k |
| Result to be appropriated | 9905 | €-34k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 20-04-2021 |
| Status | Active |
| Postal code | 2220 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12014K0821/00S000 | Flanders | 9,177 m² | 1 · 5,436 m² | 8.7 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
19-12-2024 1 director appointed, 1 resigning
- Jimmy Hofmans, Dagelijks bestuur
- Ahmadzadeh Kyarash, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ahmadzadeh Kyarash",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-07-01",
"evidence_quote": "De bijzondere algemene vergadering neemt kennis van het ontslag als bestuurder van de heer Ahmadzadeh Kyarash. Het ontslag ging in per 1 juli 2024.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Jimmy Hofmans",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": "0821.971.367",
"name": "acratio BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering geeft volmacht aan Jimmy Hofmans, bestuurder bij accratio BV (0821.971.367) voor het ondertekenen van alle documenten met het oog de publicatie in het Belgisch Staatsblad van bovenstaande beslissingen, alsook bij het ondernemingsloket en de Kruispuntbank van Ondernemingen",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "sole_shareholder_declaration",
"role": "enige_bestuurder",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-12-19",
"filing_date": "2024-10-22",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2024-10-22",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0766.921.887",
"name_full": "DNAP",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jimmy Hofmans",
"org_rep_person_name": null,
"person_role_at_subject": "gevolmachtigde"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | DNAP |